SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-135472
Filing Date
2016-11-21
Accepted
2016-11-21 06:31:37
Documents
46
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v451792_10q.htm 10-Q 285433
2 EXHIBIT 10.4 v451792_ex10-4.htm EX-10.4 52174
3 EXHIBIT 31.1 v451792_ex31-1.htm EX-31.1 10697
4 EXHIBIT 31.2 v451792_ex31-2.htm EX-31.2 10888
5 EXHIBIT 32.1 v451792_ex32-1.htm EX-32.1 4523
6 EXHIBIT 32.2 v451792_ex32-2.htm EX-32.2 4490
7 GRAPHIC pg1img1_10q.jpg GRAPHIC 16502
  Complete submission text file 0001144204-16-135472.txt   2877803

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mbrx-20160930.xml EX-101.INS 476027
9 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20160930.xsd EX-101.SCH 36764
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20160930_cal.xml EX-101.CAL 20137
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20160930_def.xml EX-101.DEF 211569
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20160930_lab.xml EX-101.LAB 264967
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20160930_pre.xml EX-101.PRE 237534
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 162009031
SIC: 2834 Pharmaceutical Preparations